MicroRNAs (miRNAs) and piwi-interacting RNAs (piRNAs) are two classes of small noncoding RNAs, both of which play roles in regulating tissue development. It is unknown whether these distinct classes of noncoding RNAs can regulate one another. Here we show that ectopic expression of miR-17 inhibited mouse fertility and early embryonic development. Specifically, we found that the piRNA amplification loop was repressed by miR-17-5p, leading to increased levels of transposition mutagenesis. This occurred by suppressing the amplification loop of piRNAs with an identical 5′ sequence and by targeting Mili/Miwi2, an essential component of the piRNA amplification loop, and the DNA methyltransferase, Dnmt3a. We also found that increased levels of piRNAs could compete with miRNAs for target binding, resulting in increased expression of Dnmt3a and Mili. Increased Dnmt3a levels could in turn block miR-17-5p expression, while increased Mili expression could accelerate piRNA amplification and inhibit transposon generation, favoring embryonic development. We report for the first time the reciprocal regulation between miRNAs and piRNAs in mouse embryonic development. 2 The discovery of miRNAs in gene regulation has improved our understanding of posttranscriptional control of tissue development and aging.
A microRNA (miRNA) is a small non-coding RNA molecule of 18-24 nucleotides in length that are post-transcriptional regulators of gene expression. A miRNA has the capacity to affect the stability of hundreds of unique mRNAs 1 and may repress synthesis of hundreds of proteins by base-pairing with the targeting mRNAs. 2 The discovery of miRNAs in gene regulation has improved our understanding of posttranscriptional control of tissue development and aging. [3] [4] [5] A polycistronic miRNA cluster, miR-17~92, consisting of six mature miRNAs (miR-17, miR-18a, mIR-19a, miR-20a, miR-19-b1, and miR-92a-1), has been reported to play a fundamental role in development and remodeling. [6] [7] [8] [9] Furthermore, members of miR-17-92 cluster are found to be commonly down-regulated in aging human cells. 10 We have found that ectopic expression of miR-17 retards tissue growth 11 and inhibits cell senescence. 12 Piwi-interacting RNA (piRNA) is the largest class of small non-coding RNAs expressed by animal cells. 13 piRNAs form complexes with piwi proteins, which function posttranscriptionally in silencing retrotransposons and other genetic elements in germ-line cells.
14 piRNA activity in gene regulation may lead to silencing of transposon expression, 15 as most piRNA sequences are antisense to transposon sequences. 16 The activity of piRNAs in transposon silencing appears to be the most important event during embryonic development. 17 To facilitate silencing transposons in the testes of mammals or in the germ cells of invertebrates, the piwi proteins play essential roles in interacting with piRNAs.
These piwi proteins are members of Argonautes, proteins that are needed for gene silencing in miRNA action, including MIWI, MIWI2 and MILI. The sequences of piRNAs guide the piwi proteins to their transposon targets. 17 Decreased expression of these PIWI proteins is correlated with increased expression of transposons, leading to potential infertility. [17] [18] [19] We have previously observed that increased expression of miR-17 retards tissue growth. 11 Further examination showed that significantly higher incidences of infertility occurred in miR-17 transgenic mice. This study was designed to uncover the role of miR-17 in embryonic development.
Results miR-17 inhibits mouse fertility and early embryo development. During the course of maintaining miR-17 transgenic mice that were established previously, 11 we found that the mice were infertile if both male and female were miR-17 transgenic. We performed a systematic analysis of the fertility of the transgenic mice. Fertility Index was calculated based on cycles of 3 weeks for pregnancy. We found that female miR-17 transgenic mice were infertile if they were matched with male miR-17 transgenic mice, but exhibited normal fertility if matched with wild-type male mice ( Figure 1a ). The fertility of wild-type female mice was not affected by matching with miR-17 transgenic mice.
To examine the cause of infertility, we isolated mouse oocytes at various time points from oviduct or uterus after hCG treatment and mating. Each group contained at least six mating pairs. In the four sets of breeding (male miR-17 transgenic: miRm; female miR-17 transgenic: miRf, male wild type: wtm; female wild type: wtf), we detected a significant decrease in embryonic number of 2 or 4-cell, morula and blastocyst in the miRm+miRf set as compared with the other three sets (Figure 1b, Supplementary Figure S1a) . The isolated embryos were cultured in M2 medium for 24 h followed by TUNEL straining. We detected significantly decreased survival rates in zygote, two-cell, and morula stages, but not in the blastocyst stage, of miR-17 transgenic mice miRm+miRf compared with the other three sets (Figure 1c,  Supplementary Figure S1b) . We confirmed expression of miR-17 precursor, mature miR-17-5p, and mature miR-17-3p (Supplementary Figure S1c) in GV, MII, sperm, and embryos in one-cell, two-cell, morula, and blastocyst stages.
We dissected the effect of mature miRNA(s) by injecting miR-17-5p, miR-17-3p, or control oligo, into the single-cell zygotes, followed by 96-h incubation and TUNEL staining. We found that injection with miR-17-5p, but not miR-17-3p, at concentrations ≥ 0.2 pg decreased zygote survival (Figure 1d , Supplementary Figure S1d ). The efficiency of injection was confirmed by real-time PCR (Figure 1e ). The injected zygotes were also cultured for 4 days, by when zygotes developed to blastocysts, and again, only injection with miR-17-5p decreased embryonic development (Figure 1f) . We tested the effect of another miRNA miR-20a that is highly homologous to miR-17-5p and detected a similar function in embryonic development (Figure 1g) .
To test the functions of endogenous miR-17-5p, we injected zygotes with inhibitors of miR-17-5p and miR-17-3p, followed by 96-h culture and TUNEL staining. We found that only miR-17-5p inhibitor enhanced zygote survival and development ( Figure 1h, Supplementary Figure S1e) . In these experiments, 10-12 embryos were injected in each group, and each experiment was repeated four times.
Repression of piRNA expression. As piRNAs play important roles in the early embryonic development, we analyzed levels of piRNA expression, focusing on the piRNAs with sequences homologous to the 5′ seed region of miR-17-5p (Figure 2a ) using the website http://pirnabank.ibab.ac.in. These piRNAs were organized into Group I (having six nucleotides at the 5′ end of the piRNAs that were homologous to miR-17-5p seed region), Group II (having six nucleotides anti-sense to the seed region of miR-17-5p), Group III (having more than six nucleotides homologous to miR-17-5p), Group IV (having five nucleotides homologous to miR-17-5p), Group V (six nucleotides at the middle of the piRNAs), and Group VI (six nucleotides at the 3′ end of the piRNAs). We found that expression of eight piRNAs in Group I was downregulated in the oocytes of miR-17 transgenic mice compared with that of wild type (Figure 2b ). Expression of Group II piRNAs was also downregulated in the miR-17 transgenic mice (Supplementary Figure S2a) . Analysis of these two groups of piRNAs indicated significant decrease in the number of oocyte, sperm, and embryos in various stages (Figure 2c) . Analysis of the average changes of piRNAs indicated that Group III piRNAs had similar fold changes as Group I piRNAs, while Group IV, Group V, and Group VI piRNAs had little change when compared with controls ( Figure 2d) .
To test the effect of miR-17-5p on piRNA expression, we injected oocytes with miR-17-5p and miR-17-3p. We found that injection with miR-17-5p displayed a general decrease of piRNA expression (Figure 2e ). Oocytes were also injected with miR-17-5p inhibitor. The injection displayed a general increase in piRNA levels (Figure 2f) .
To test the effect of piRNAs on embryonic survival and development, we injected oocytes with five piRNAs in Group I. The injected oocytes were cultured for 4 days, followed by TUNEL staining. We detected a significant increase in oocyte survival and development (Figure 2g , Supplementary Figure S2b) .
Derepression of transposons.
It has been known that piRNAs play roles in repressing transposon activity allowing embryonic development. 17 We analyzed transposon levels in the zygotes of miR-17 transgenic and wild-type mice by measuring the levels of transposon markers Line1, MuERV, and IAP. 20, 21 Real-time PCR analysis indicated that all of these markers were significantly upregulated in the miR-17 transgenic zygotes compared with wild type (Figure 3a) . To dissect the effect of both miR-17-5p and miR-17-3p, we injected wild-type zygotes with miR-17-5p, miR-17-3p, and control oligos, followed by analysis of transposon levels. We found that only miR-17-5p injection increased transposon levels, while injection with miR-17-3p did not produce any effect (Figure 3b) .
To examine the general effects of miR-17 on derepression of transposon, we isolated RNAs from GV, M-II, sperm, one-cell embryos, two-cell embryos, morulas, and blastocysts. We confirmed that the levels of MuERV (Figure 3c ), Line1, IAP, and MT (Supplementary Figure S2c) were significantly upregulated mainly in one-cell to morula stages.
It has been known that piRNAs play roles in repressing transposons. 17 We injected zygotes with piRNA (piR-11) and confirmed that injection with piR-11 repressed transposon levels (Supplementary Figure S2d) . Further analysis indicated that injection with piR-11 enhanced methylation levels of retrotransposon LINE1, MuERV, and IAP (Figure 3d ). To test whether piRNAs might be mediating miR-17's effect on methylation of transposons, we analyzed the transposon levels of zygotes isolated from miR-17 transgenic and wildtype mice. Methylation levels of Line1, MuERV, and IAP were significantly lower in the miR-17 transgenic zygotes than the wild-type zygotes (Figure 3e) . To validate the effect of miR-17 on reducing transposon level, isolated zygotes were injected with miR-17-5p, miR-17-3p, and control oligos. The experiment confirmed that injection with miR-17-5p decreased transposon methylation, while injection with miR-17-5p inhibitor increased it (Figure 3f ). miR-17-5p targeted Mili and Dnmt3a. We analyzed expression of a number of enzymes responsible for DNA methylation, including Mili, Mili2, Dnmt3a, Dnmt3b, and Dnmt3I, by real-time PCR. We found that Mili and Dnmt3a were significantly repressed in the miR-17 transgenic zygotes compared with the wild-type zygotes (Figure 4a ). We examined expression of these two proteins in blastocysts and found that they were largely repressed in the miR-17 transgenic blastocysts compared with the wild-type blastocysts ( Figure 4b ) and other stages, including zygotes, twocell, and morula (Supplementary Figure S3a) . Nevertheless, significant repression of Mili and Dnmt3a mRNA was only detected in the one-cell and two-cell stages (Supplementary Figure S3b) . Consistent with these results, we did not detect repression of Mili and Dnmt3a proteins in the ovaries and testis of miR-17 transgenic mice (Supplementary Figure S3c) . To corroborate these results, we co-injected zygotes with miR-17-5p and purified Dnmt3a or Mili. While injection with miR-17-5p inhibited zygote development, coinjection with Dnmt3a and/or Mili significantly abolished the miR-17-5p effect (Figure 4c ). Computational analysis (http://bio.sz.tsinghua.edu.cn/) indicated that both Mili and Dnmt3a were the potential targets of miR-17-5p (Figure 4d , upper). We generated luciferase constructs harboring the potential target sites and mutant constructs in which the miR-17-5p binding sites were mutated. Luciferase assays showed reduction of luciferase activities when the constructs containing miR-17-5p binding sites were co-transfected with miR-17-5p mimic (Figure 4d, lower) . Mutations of the binding sites abolished the repression effect of miR-17-5p.
We confirmed the effect of miR-17-5p on regulating Dnmt3a and Mili by silencing miR-17-5p. Transfection with miR-17-5p inhibitor decreased the effect of endogenous miR-17-5p on the activities of Luc-Dnmt3a-1 and Luc-Mili in a dose-dependent manner ( Figure 4e ). Co-transfection with piRNA also decreased the effect of miR-17-5p on regulating Luc-Mili activity in a dose-dependent manner (Figure 4f ).
To further validate that effect of miR-17-5p, we injected zygotes with miR-17-5p, miR-17-3p, and control oligos, followed by immunostaining with antibodies against Mili and Dnmt3a. We confirmed repression of Mili and Dnmt3a when the zygotes were injected with miR-17-5p (Supplementary Figure S4a) . The levels of Mili and Dnmt3a mRNAs were also repressed by miR-17-5p (Supplementary Figure S4b) .
We then tested the effect of endogenous miR-17-5p by injecting zygotes with the inhibitors of miR-17-5p, miR-17-3p, and control oligos. Upregulation of Mili and Dnmt3a was detected in zygotes injected with miR-17-5p inhibitor at the protein ( Figure 4g ) and mRNA (Supplementary Figure S4c To validate the methylation activity of Mili and Dnmt3a, we injected zygotes with purified Mili and Dnmt3a or antibodies against these proteins, followed by methylation analysis. We confirmed that injection with Mili and Dnmt3a increased methylation of Line1, MuERV, and IAP (Figure 5a ), while injection with the antibodies inhibited these processes (Supplementary Figure S5a) . As a consequence, injection with Mili and Dnmt3a decreased transposon levels (Figure 5b ), while injection with the antibodies increased transposon levels (Supplementary Figure S5b) . Injection of Mili and Dnmt3a methylated all miRNA promoters tested ( Figure 5c ) and decreased expression of miRNAs driven by these promoters (Supplementary Figure S5c) . On the other hand, injection with anti-Mili or anti-Dnmt3a antibodies decreased promoter methylation ( Figure 5d ) and increased miRNA expression (Supplementary Figure S5d) .
To analyze the observed decrease in methylation as a result of repressing Mili and Dnmt3a, we injected zygotes with miR-17-5p mimic and detected decreased methylation of miRNA promoters (Figure 5e ) but increased expression of miRNAs associated with these promoters (Supplementary Figure S6a) . Injection of miR-17-5p inhibitor increased methylation of these promoters (Figure 5f ) but decreased expression of these miRNAs (Supplementary Figure S6b) . Consistently, we detected increased expression of a number of miRNAs in the miR-17 transgenic mice as compared with wild-type mice (Supplementary Figure S6c, left) , which occurred through decreased methylation of miRNA promoters (Supplementary Figure S6c, right) . We examined whether the increased miRNA levels occurred through a normal miRNA biogenesis pathway. The levels of miRNAs in the zygotes of miR-17 mice were upregulated when we performed immunoprecipitation with anti-Ago2 antibody (Figure 5g ).
piRNAs compete with miRNAs. We tested whether piRNAs with sequences homologous to the miR-17-5p seed region could compete with miR-17-5p function in repressing Mili and Dnmt3a expression. Zygotes were injected with piR-11 and piR-12 followed by immunostaining for Mili and Dnmt3a levels. We found that injection with piRNAs increased Mili and Dnmt3a expression (Figure 6a ). Their mRNA levels were also found to be higher by injecting zygotes with piR-11 ( Figure 6b ). Promotion of Dnmt3a expression by piR-11 injection was consequently followed by methylation of miRNA promoters tested ( Figure 6c ) and downregulation of miRNA expression (Figure 6d ). Promotion of Dnmt3a and Mili by piR-11 injection was also found to increase piRNA expression (Figure 6e ). To confirm the effects of Mili and Dnmt3a on piRNA expression, we injected zygotes with Mili and Dnmt3a. We confirmed that injection of the zygotes with Mili and Dnmt3a increased not only the piRNAs with sequences homologous to the miR-17-5p seed region, but also other unrelated piRNAs (Figure 6f) , suggesting a general effect of these two proteins on piRNA biogenesis. Injection with antibodies against Mili and Dnmt3a decreased piRNA expression (Supplementary Figure S7a) . When piRNA expression was upregulated as a consequence of increased Mili and Dnmt3a levels, the increased piRNAs would compete with miR-17-5p function. As a consequence, expression of Mili and Dnmt3a was found to be upregulated at the mRNA (Supplementary Figure S7b) and protein (Figure 6g ) levels.
In summary, we demonstrated a relationship between miRNAs and piRNAs in regulating mouse fertility and early embryonic development. Ectopic expression of miR-17-5p suppressed the amplification loop of piRNAs with identical sequences in the 5′ of the piRNAs to the seed region of miR-17-5p. This silenced the effect of piRNAs in the repression of transposons, leading to embryonic infertility (Figure 7a ). On the other hand, increased levels of piRNAs blocked the function of miR-17-5p in gene targeting (Figure 7b ). For instance, miR-17-5p repressed essential components of the piRNA amplification loop, Mili/Miwi2, and the DNA methytransferase, Dnmt3a, both of which play important roles in regulating piRNA activities and embryonic development (Figure 7c ).
Discussion
As the largest class of small non-coding RNAs, piRNAs can repress the functions of their targets with the assistance of piwi proteins, members of the Argonautes, in a manner similar to miRNAs. 22 The piRNAs differ from microRNA in size. While miRNAs have 18-24 nucleotides, piRNAs are 26-31 nucleotides in size. miRNAs are highly conserved across different species, whereas piRNAs lack sequence conservation with increased complexity. The number of unique piRNAs can be as many as 4-5-folds that of miRNAs. The relationship between miRNAs and piRNAs in the early stages of development is summarized in a review article. 23 A recent study showed that miRNAs play roles in the biogenesis and stability of Drosophila piRNAs. 24 In mammals, it remains unclear how piRNAs are generated, although it is certain that the biogenesis pathway of piRNAs is distinct from that of miRNAs. 25 The possible mechanism of the piRNA biogenesis pathway appears to be a 'Ping-Pong' mechanism. Evidence was obtained from the observation that piRNA sequences have a strand bias: they are the products of one DNA strand, suggesting that they are produced from a single-strand transcript. 13 This 'Ping-Pong' mechanism is also called the piRNA amplification loop (Figure 7b ). In the loop, piRNA precursors are transcribed, producing piRNAs with a tendency to target 5′ uridines. 26 In addition, it is proposed that the primary piRNAs bind to their complementary targets followed by the recruitment of the Piwi proteins, or the Argonautes. This induces cleavage of the transcript at a point 10 nucleotides away from the 5′ end of the primary piRNA, producing a secondary piRNA. 26 This amplification loop can generate a large number of piRNAs with complexity.
In the early stages of embryonic development, it is essential to produce a large number of piRNAs with significant complexity. These piRNAs can induce DNA methylation and inhibit transposon activity, representing an essential step in embryonic development. We have found that ectopic expressed miR-17-5p competed with endogenous piRNAs in the generation of piRNAs in the amplification loop. Specifically, the seed region of miR-17-5p competed with piRNAs whose 5′' segments contain sequences identical to the seed region of miR-17-5p. This does not allow the piRNAs to bind to their target transposons. As a result, the piRNA amplification loop is disrupted by miR-17-5p overexpression, leading to increased activities of transposons and inhibition of embryonic development.
Although our results showed that only the piRNAs with sequences homology to the seed region of miR-17-5p had roles in embryonic development, other piRNAs, besides those used as controls in this study, may also have roles in development by way of targeting developmental element transposons. Furthermore, miR-17-5p may target other molecules that also have roles in embryonic development, as a miRNA can potentially target several hundreds of mRNAs. 1, 2 As well, other miRNAs may target Mili and Dnmt3a and modulate embryonic development, as an mRNA can be targeted by many miRNAs. 27 Nevertheless, miR-17-3p, a miRNA generated from the same precursor of miR-17, was not able to repress expression of Mili and Dnmt3a and had no effect on embryonic development. This is different from our previous study showing that both miR-17-5p and the passenger strand miR-17-3p could target the same molecule, TIMP3, leading to increased prostate tumor growth and invasion. 28 It suggests that the micro-environments are essential in determining the function of a miRNA.
Reciprocally, our results showed that increased levels of piRNAs with sequences identical to the seed region of miR-17-5p could block the activity of miR-17-5p in gene targeting. The results suggest that these piRNAs could bind to the potential targets of miR-17-5p without repressing the expression and functions of the targets. Instead, they interfere with the binding of miR-17-5p to the potential targets. Our results also confirm that the functions of piRNAs are distinct from those of miRNAs, as they use different Argonaute proteins.
In a cell, a miRNA or a piRNA may predominate the function of the others, as the number of Argonaute molecules cannot be unlimitedly expressed. As such, the miRNAs with sig- nificantly increased levels may predominantly occupy Argonaute molecules, resulting in the degradation of other miRNAs or piRNAs, 29 following the strategy of 'Use it or lose it'. Therefore, a distinct function of infertility could be clearly observed in the miR-17 transgenic mice. In the embryonic injection, we anticipate that the levels of increased miR-17-5p or piRNAs could be much higher than those in physiological conditions, resulting in amplified effects of the microinjection.
In our study, we identified two important targets of miR-17-5p: Miwi2/Mili and Dnmt3a, both of which have essential roles in embryonic development. While MIWI2/Mili is essential for spermatogenesis and repression of transposons in the mouse male germ line, 30 Dnmt3a is an enzyme that catalyzes DNA methylation. 31 While DNA methylation facilitates the inhibitory effect of piRNAs on transposon expression and has important roles in embryonic development, 32 we found that Dnmt3a could methylate the miR-17 promoter, producing a feedforward loop. This feed-forward loop maintained high levels of miR-17-5p, leading to embryonic infertility. For example, when the level of miR-17-5p is high, it would repress Dnmt3a expression. This would decrease methylation of the miR-17 promoter, allowing increased expression of miR-17-5p. When the level of miR-17-5p is low, its inhibitory effect on Dnmt3a expression is suspended. The increased expression of Dnmt3a could methylate the miR-17 promoter, decreasing miR-17-5p expression. This feed-forward loop may explain the in vivo effect of infertility in the mice expressing miR-17-5p. This feed-forward loop appears to play essential roles in the early stages of development. The clinical significance of this feed-forward loop awaits further investigation.
Materials and Methods
Materials. The monoclonal antibodies against Mili and Ago2 were obtained from Cell Signaling (Danvers, MA, USA). The monoclonal antibodies against Dnmt3a and β-actin were obtained from Abcam (Cambridge, MA, USA). RNA and DNA extract kits, miRNA RT and PCR kits, and EpiTect Bisulfite kit were obtained from Qiagen (Hilden, Germany). M2 embryo culture medium, pregnant mare serum gonadotropin (PMSG) and human chronic gonadotropin (hCG) were from Sigma-Aldrich (St. Louis, MO, USA), and CZB medium was obtained from EMD Millipore (Billerica, MA, USA).
Constructs and primers. Plasmid miR-17 and control plasmid were generated previously. Both plasmids contain a Bluescript backbone, a CMV promoter driving green fluorescent protein (GFP) expression, and a human H1 promoter driving pre-miR-17 or a non-related sequence serving as a control. The pMir-Report (Ambion, Frederick, MD, USA), luciferase reporter vector, was used to generate the luciferase constructs. A fragment of the 3'-untranslated region (3'UTR) of mouse Mili and Dnmt3a was cloned by RT-PCR. Two primers, musMili-SacI and musMili-MluI, were synthesized to clone the 3'UTR fragment of Mili. All primer sequences used are listed in Supplementary Figure S7c . Two 3'UTR fragments of Dnmt3a were cloned with the primers musDnmt3a-1-SacI and musDnmt3a-1-MluI, and primers musDnmt3a-2-SacI and musDnmt3a-2-MluI. The PCR products were digested with SacI and MluI and the fragments were inserted into the luciferase vector to obtain Luc-Mili, Luc-Dnmt3a-1, and Luc-Dnmt3a-2. The mutant constructs Luc-Mili-mut mutation of the miR-17-5p binding site were generated by using the PCR approach with primers musMili-SacI and musMili-MluI-mut. Primers musDnmt3a-1-ScaI and musDnmt3a-1-MluI-mut, and primers musDnmt3a-2-ScaI and musDnmt3a-2-MluI-mut were used to generate the Luc-Dnmt3a-1-mut and Luc-Dnmt3a-2-mut constructs. A non-related sequence, amplified from the coding sequence of the chicken versican G3 domain, was used as a negative control, as previously.
Transgenic mice. The miR-17 transgenic mice were generated previously.
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Transgenic lines were maintained by backcrossing with F1 (C57BL/6XCBA) wildtype mice. Male mice used in this study were between 8 to 12 weeks of age, and the female between 3 to 4 weeks. They were maintained under 12 h light/ 12 h dark photoperiod at a room temperature of 22-23 1C and relative humidity 50%. All animal experiments were approved by the Animal Care Committee of Sunnybrook Research Institute, Ontario, Canada. Genotyping was performed by PCR, using primers EGFP-347F pairing with EGFP-668R for CMV promoter and EGFP981F pairing with EGFP-CApaI for GFP coding sequence, with tail snip or ear punch DNA as template. Mouse GAPDH served as a control using primers muGapdh1F and muGapdh250R.
Collection of epididymal sperms and oocytes. The cauda epididymidis was removed from male mice and the epididymal fluid was squeezed out and placed on the bottom of a 1.5-ml tube containing 0.5 ml CZB medium for use. Fully grown GV oocytes were collected from the ovaries of female mice and cultured under mineral oil (Sigma-Aldrich) in M2 or CZB medium at 37 1C, 5% CO 2 . For collection of unfertilized or fertilized oocytes, females were induced to superovulate with intraperitoneal injection of 5 IU PMSG and 5 IU hCG given 48 h apart. To obtain unfertilized oocytes, the PMSG and hCG were injected, and the oviducts were removed 14 h after the injection of hCG. The cumulus − oocyte complexes were released from the oviducts into 0.1% bovine testicular hyaluronidase in M2 medium to disperse cumulus cells. The cumulus-free oocytes were washed with M2 medium and cultured in M2 or CZB medium. To collect fertilized oocytes (embryos), PMSG and hCG were injected. Females were mated with males after hCG injection, and the oviducts and uteruses were removed 24, 48, 72 or 96 h after hCG injection. All the fertilized oocytes (embryos) were collected from oviducts or uteruses under the dissecting microscope, washed with M2 medium, and in M2 or CZB medium.
Immunofluorescent staining. The early embryos were fixed in 3.7% formaldehyde in phosphate-buffered saline (PBS) for 20 min. After washing three times in PBS, embryos were treated with 0.5% Triton X-100 (Sigma-Aldrich) in PBS for 30 min, blocked with 10% goat serum for 1 h at room temperature, and then incubated with primary antibody in PBS containing 10% goat serum albumin overnight. The embryos were washed and stained with goat anti-rabbit Alexa 488 (Life Technologies, Carlsbad, CA, USA) at room temperature for 1 h. Fluorescent phalloidins, Acti-stain 555 (Sigma-Aldrich), was used to stain F-actin to show cell structure. DNA staining was performed with DAPI. Confocal laser scanning microscopy was performed using an LSM 510 Meta microscope (Carl Zeiss, Oberkochen, Germany).
Immunohistochemistry. We followed the techniques as described. 33 Briefly, tissues were freshly excised and fixed in 10% formalin over 24 h, immersed in 70% ethanol, embedded in wax, and sectioned. The sections were de-paraffinized with xylene and ethanol and then boiled in a pressure cooker. After blocked with 10% goat serum for half an hour, all samples were incubated with primary antibody at 4°C overnight. The sections were incubated with biotinylated secondary antibody for 1-2 h, followed by avidin conjugated horseradish peroxidase provided by the Vectastain ABC kit (Vector, PK-4000, Burlingame, CA, USA). The slides were then stained with DAB followed by Mayer's Hematoxylin counterstaining.
Protein extract and purification. To cross-link antibodies to protein A-Sepharose, a slurry of Protein A-Sepharose was incubated with antibodies to destined proteins at 4°C for 2 h, and incubated in borate/NaCl buffer (0.04 M boric acid, 40 mM sodium tetraborate decahydrate, 3M NaCl, pH 9.0) with 20 mM DMP at room temperature for 30 min. Unreacted DMP was quenched with ethanolamine buffer (200 mM ethanolamine, pH 8.0) for 2 h, and the cross-linked beads were kept in PBS with 0.01% merthiolate (Sigma-Aldrich) at 4°C. The ovary tissues were lysed and incubated with antibodies (against Mili or Dnmt3a) cross-linked with protein A-Sepharose at 4°C for 2 h, mixed with 3 volumes of 0.2 M glycine (pH 2.6) and centrifuged. The eluted supernatant was neutralized by equal volume of 1 M Tris buffer (pH 8.0). The precipitated proteins were purified and concentrated with Amicon Ultra Centrifugal Filters (Merck Millipore, Darmstadt, Germany) and quantified before microinjection.
Microinjection. Microinjection was performed with Eppendorf microinjector 5246. Zygotes collected in M2 medium at 24 h after hCG injection were microinjected with 2 pl of 20-100 ng/μl miRNA mimics, miRNA antisenses, or piRNA mimics. Approximately 1-2 pl of 200 ng/μl proteins or antibodies were microinjected into the cytoplasm of the above early zygotes. After injection, the embryos were cultured in CZB medium under mineral oil at 37 o C in an atmosphere of 5% CO 2 for 8 or 96 h.
Real-time PCR. For mature miRNA, piRNA and endogenous siRNA analysis, total RNAs were extracted from 30−50 embryos with mirVana miRNA Isolation Kit (Ambion) according to the manufacturer's instructions. cDNA synthesis was performed with miScript Reverse Transcription Kit (Qiagen), using 1 μg RNA as template as described. 34 PCRs were performed with miScriptSYBR GreenPCR Kit (Qiagen) using 1 μl cDNA as templates. Mouse U6 was used as a real-time PCR control. DNA methylation assay. DNA methylation levels were assessed by Methylation-Specific PCR (MSP). Genomic DNA was extracted from the harvested embryos (80-100) using the QIAmp DNA mini kit (Qiagen). Bisulfite treatment of genomic DNA was performed using the EpiTect Bisulfite Kit (Qiagen) according to the manufacturer's protocol. The MSP primers were designed using the MethPrimer software (http://www.urogene.org/methprimer). PCRs were performed with miScriptSYBR GreenPCR Kit (Qiagen) using 1 μl DNA as templates, with mouse GAPDH as a real-time PCR control.
RNA-binding protein immunoprecipitation assay (RIP). A total of 80-100 embryos were washed in ice-cold PBS, lysed in 200 μl lysis buffer, and incubated with 5 μg primary antibody at 4°C for 2 h. Forty microliters of 50% slurry of protein A-Sepharose was added to each sample, and the mixtures were incubated at 4°C for 4 h. The pellets were washed three times with PBS and resuspended in 0.5 ml Tri Reagent (Sigma-Aldrich). Eluted, coprecipitated RNA in the aqueous was subjected to qRT-PCR analysis to demonstrate the presence of the binding using respective primers.
Luciferase activity assay. A dual-luciferase reporter system (Promega) was used to perform luciferase activity assay as described. 35 Briefly, MEF cells were cultured on 12-well tissue culture plates at a density of 2 × 10 5 cells per well. Cells were co-transfected with the luciferase reporter constructs, corresponding miRNA mimics, and Renilla luciferase construct for 5-6 h. After culturing for 24 h, the transfected cells were lysed by 150 μl of passive lysis buffer. Thirty microliters of Statistical analysis. All experiments were performed in triplicate and numerical data were subjected to independent-samples t test. The levels of significance were set at *Po0.05 and **Po0.01.
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